Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale : a case study of two zinc lozenge trials

Show full item record



Permalink

http://hdl.handle.net/10138/189037

Citation

Hemilä , H 2017 , ' Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale : a case study of two zinc lozenge trials ' , BMC Medical Research Methodology , vol. 17 , 82 . https://doi.org/10.1186/s12874-017-0356-y

Title: Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale : a case study of two zinc lozenge trials
Author: Hemilä, Harri
Other contributor: University of Helsinki, Harri Hemilä / Principal Investigator


Date: 2017-05-12
Language: eng
Number of pages: 9
Belongs to series: BMC Medical Research Methodology
ISSN: 1471-2288
DOI: https://doi.org/10.1186/s12874-017-0356-y
URI: http://hdl.handle.net/10138/189037
Abstract: Background: The relative scale has been used for decades in analysing binary data in epidemiology. In contrast, there has been a long tradition of carrying out meta-analyses of continuous outcomes on the absolute, original measurement, scale. The biological rationale for using the relative scale in the analysis of binary outcomes is that it adjusts for baseline variations; however, similar baseline variations can occur in continuous outcomes and relative effect scale may therefore be often useful also for continuous outcomes. The aim of this study was to determine whether the relative scale is more consistent with empirical data on treating the common cold than the absolute scale. Methods: Individual patient data was available for 2 randomized trials on zinc lozenges for the treatment of the common cold. Mossad (Ann Intern Med 125:81-8, 1996) found 4.0 days and 43% reduction, and Petrus (Curr Ther Res 59:595-607, 1998) found 1.77 days and 25% reduction, in the duration of colds. In both trials, variance in the placebo group was significantly greater than in the zinc lozenge group. The effect estimates were applied to the common cold distributions of the placebo groups, and the resulting distributions were compared with the actual zinc lozenge group distributions. Results: When the absolute effect estimates, 4.0 and 1.77 days, were applied to the placebo group common cold distributions, negative and zero (i.e., impossible) cold durations were predicted, and the high level variance remained. In contrast, when the relative effect estimates, 43 and 25%, were applied, impossible common cold durations were not predicted in the placebo groups, and the cold distributions became similar to those of the zinc lozenge groups. Conclusions: For some continuous outcomes, such as the duration of illness and the duration of hospital stay, the relative scale leads to a more informative statistical analysis and more effective communication of the study findings. The transformation of continuous data to the relative scale is simple with a spreadsheet program, after which the relative scale data can be analysed using standard meta-analysis software. The option for the analysis of relative effects of continuous outcomes directly from the original data should be implemented in standard meta-analysis programs.
Subject: Data interpretation
Meta-analysis
Outcome assessment
Randomized controlled trial
Respiratory tract infections
Statistics
Zinc lozenges
DOUBLE-BLIND
GLUCONATE LOZENGES
MEAN DIFFERENCES
METAANALYSIS
RATIO
SIMULATION
VARIABLES
SYMPTOMS
ACETATE
SMOKING
3141 Health care science
3142 Public health care science, environmental and occupational health
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Duration_of_the_common_cold.pdf 592.7Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record